Description
Ozempic contains semaglutide and is licensed for the management of type 2 diabetes, improving blood sugar control alongside diet and exercise.
Semaglutide works by mimicking the naturally occurring GLP-1 hormone, signaling fullness to the brain and slowing gastric emptying. Weight loss has been observed as a secondary effect of this mechanism in clinical use, but Ozempic itself is not licensed as a weight-loss treatment. Wegovy contains the same active ingredient at a dose and indication specifically approved for chronic weight management.
Ozempic is a prescription-only medicine for patients with a confirmed type 2 diabetes diagnosis. Eligibility is assessed through a medical questionnaire reviewed by our clinical team, and a prescription is issued only where it is clinically appropriate. Do not start, stop, or change your dose without direction from your prescriber.







Reviews
There are no reviews yet.